A Novel Mouse Model of Intrahepatic Cholangiocarcinoma Induced by Azoxymethane
International Journal of Molecular Sciences · 26.09.2023 · 24 (19) · 14581
DOI: 10.3390/ijms241914581 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.09.2023. Verfasst von Yohei Shirakami und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (2017).
Abstract (Originalsprache)
Cholangiocarcinoma is the second most common primary cancer of the liver and has a poor prognosis. Various animal models, including carcinogen-induced and genetically engineered rodent models, have been established to clarify the mechanisms underlying cholangiocarcinoma development. In the present study, we developed a novel mouse model of malignant lesions in the biliary ducts induced by the administration of the carcinogen azoxymethane to obese C57BLKS/J-db/db mice. A histopathological analysis revealed that the biliary tract lesions in the liver appeared to be an intrahepatic cholangiocarcinoma with higher tumor incidence, shorter experimental duration, and a markedly increased incidence in obese mice. Molecular markers analyzed using a microarray and a qPCR indicated that the cancerous lesions originated from the cholangiocytes and developed in the inflamed livers. These findings indicated that this is a novel mouse model of intrahepatic cholangiocarcinoma in the context of steatohepatitis. This model can be used to provide a better understanding of the pathogenic mechanisms of cholangiocarcinoma and to develop novel therapeutic strategies for this malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
- Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
- Department of Pathological Diagnosis, Gifu Municipal Hospital, Gifu 500-8513, Japan.
ORCID-Profile: Yohei Shirakami, Daisuke Taguchi, Hiroyuki Tomita, Takuji Tanaka, Masahito Shimizu
Förderung
- Japan Society for the Promotion of Science
- Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (2017)
Zitieren
APA
Shirakami, Y., Kato, J., Ohnishi, M., Taguchi, D., Maeda, T., Ideta, T., Kubota, M., Sakai, H., Tomita, H., Tanaka, T., & Shimizu, M. (2023). A Novel Mouse Model of Intrahepatic Cholangiocarcinoma Induced by Azoxymethane. International Journal of Molecular Sciences, 24(19), 14581. https://doi.org/10.3390/ijms241914581
Vancouver
Shirakami Y, Kato J, Ohnishi M, Taguchi D, Maeda T, Ideta T, et al. A Novel Mouse Model of Intrahepatic Cholangiocarcinoma Induced by Azoxymethane. International Journal of Molecular Sciences. 2023;24(19):14581. doi:10.3390/ijms241914581
BibTeX
@article{Shirakami2023,
author = {Shirakami, Yohei and Kato, Junichi and Ohnishi, Masaya and Taguchi, Daisuke and Maeda, Toshihide and Ideta, Takayasu and Kubota, Masaya and Sakai, Hiroyasu and Tomita, Hiroyuki and Tanaka, Takuji and Shimizu, Masahito},
title = {A Novel Mouse Model of Intrahepatic Cholangiocarcinoma Induced by Azoxymethane},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {19},
pages = {14581},
doi = {10.3390/ijms241914581}
}
EUVIMED